| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $736.5M | $792.1M | $1.25B |
| YoY Revenue Growth % | -7.0% | -36.8% | — |
| Gross Profit | $73.7M | $59.0M | — |
| Gross Margin % | 10.0% | 7.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$203.4M | -$258.8M | -$443.6M |
| Operating Margin % | -27.6% | -32.7% | -35.4% |
| Net Income (GAAP) | -$294.2M | -$339.6M | -$487.4M |
| EBITDA (Normalized) | -$128.5M | -$160.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$166.3M | -$77.9M | -$665.3M |
| Capital Expenditures (CapEx) | $93.6M | $122.8M | — |
| Free Cash Flow (FCF) | -$259.9M | -$200.7M | -$665.3M |
| FCF Margin % | -35.3% | -25.3% | -53.1% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $133.9M | $216.4M | — |
| Total Debt (Short + Long Term) | $316.4M | $376.3M | — |
| Total Stockholders' Equity | -$392.1M | -$202.1M | — |